Page 130 - Read Online

Page 234 Musumeci et al. J Transl Genet Genom 2020;4:221-37 I https://doi.org/10.20517/jtgg.2020.22

et al, editors. GeneReviews® [Internet]. Seattle: University of Washington; 2015. pp. 1993-2020.
29. Wedatilake Y, Brown RM, McFarland R, Yaplito-Lee J, Morris AA, et al. SURF1 deficiency: a multi-centre natural history
study. Orphanet J Rare Dis 2013;8:96.
30. Baide-Mairena H, Gaudó P, Marti-Sánchez L, Emperador S, Sánchez-Montanez A, et al. Mutations in the mitochondrial complex
I assembly factor NDUFAF6 cause isolated bilateral striatal necrosis and progressive dystonia in childhood. Mol Genet Metab
2019;126:250-8.
31. Carrozzo R, Dionisi-Vici C, Steuerwald U, Lucioli S, Deodato F, et al. SUCLA2 mutations are associated with mild methylmalonic
aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 2007;130:862-74.
32. Desai R, Frazier AE, Durigon R, Patel H, Jones AW, et al. ATAD3 gene cluster deletions cause cerebellar dysfunction associated with
altered mitochondrial DNA and cholesterol metabolism. Brain 2017;140:1595-610.
33. Maas RR, Iwanicka-Pronicka K, Kalkan Ucar S, Alhaddad B, AlSayed M, et al. Progressive deafness-dystonia due to SERAC1 mutations:
a study of 67 cases. Ann Neurol 2017;82:1004-15.
34. Heimer G, Kerätär JM, Riley LG, Balasubramaniam S, Eyal E, et al. MECR mutations cause childhood onset dystonia and optic atrophy,
a mitochondrial fatty acid synthesis disorder. Am J Hum Genet 2016;99:1229-44.
35. Engl G, Florian S, Tranebjaerg L, Rapaport D. Alterations in expression levels of deafness dystonia protein 1 affect mitochondrial
morphology. Hum Mol Genet 2012;21:287-99.
36. Aguirre LA, del Castillo I, Macaya A, Medá C, Villamar M, et al. A novel mutation in the gene encoding TIMM8a, a component of the
mitochondrial protein translocase complexes, in a Spanish familial case of deafness-dystonia (Mohr-Tranebjaerg) syndrome. Am J Med
Genet A 2006;140:392-7.
37. Meire FM, Van Coster R, Cochaux P, Obermaier-Kusser B, Candaele C, et al. Neurological disorders in members of families with Leber’s
hereditary optic neuropathy (LHON) caused by different mitochondrial mutations. Ophthalmic Genet 1995;16:119-26.
38. Nikoskelainen EK, Marttila RJ, Huoponen K, Juvonen V, Lamminen T, et al. Leber’s ‘plus’: neurological abnormalities in patients with
Leber’s hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995;59:160-4.
39. Simon DK, Friedman J, Breakefield XO, Jankovic J, Brin MF, et al. A heteroplasmic mitochondrial complex I gene mutation in adult-
onset dystonia. Neurogenetics 2003;4:199-205.
40. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene
associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994;91:6206-10.
41. Mercuri MA, White H, Oliveira C. Vision loss and symmetric basal ganglia lesions in leber hereditary optic neuropathy. J
Neuroophthalmol 2017;37:411-3.
42. Marie SK, Carvalho AA, Fonseca LF, Carvalho MS, Reed UC, et al. Kearns-Sayre syndrome ‘plus’. Classical clinical findings and
dystonia. Arq Neuropsiquiatr 1999;57:1017-102.
43. Sudarsky L, Plotkin GM, Logigian EL, Johns DR. Dystonia as a presenting feature of the 3243 mitochondrial DNA mutation. Mov
Disord 1999;14:488-91.
44. Peng Y, Crumley R, Ringman JM. Spasmodic dysphonia in a patient with the A to G transition at nucleotide 8344 in mitochondrial DNA.
Mov Disord 2003;18:716-8.
45. Hinnell C, Haider S, Delamont S, Clough C, Hadzic N, et al. Dystonia in mitochondrial spinocerebellar ataxia and epilepsy syndrome
associated with novel recessive POLG mutations. Mov Disord 2012;27:162-3.
46. Morimoto N, Nagano I, Deguchi K, Murakami T, Fushimi S, et al. Leber hereditary optic neuropathy with chorea and dementia
resembling Huntington disease. Neurology 2004;63:2451-452.
47. Nakagaki H, Furuya J, Santa Y, Nagano S, Araki E, et al. A case of MELAS presenting juvenile-onset hyperglycemic chorea-ballism.
Rinsho Shinkeigaku 2005;45:502-5.
48. Kang JH, Kang SY, Choi JC, Lee SS, Kim JS. Chorea triggered by hyperglycemia in a maternally inherited diabetes and deafness
(MIDD) patient with the A3243G mutation of mitochondrial DNA and basal ganglia calcification. J Neurol 2005;252:103-5.
49. Lahiri D, Sawale VM, Banerjee S, Dubey S, Roy BK, et al. Chorea-ballism as a dominant clinical manifestation in heteroplasmic
mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation in mitochondrial genome: a case
report. J Med Case Rep 2019;13:63.
50. Finsterer J. Parkinson syndrome as a manifestation of mitochondriopathy. Acta Neurol Scand 2002;105:384-9.
51. Finsterer J. Parkinson’s syndrome and Parkinson’s disease in mitochondrial disorders. Mov Disord 2011;26:784-91.
52. Thyagarajan D, Bressman S, Bruno C, Przedborski S, Shanske S, et al. A novel mitochondrial 12SrRNA point mutation in parkinsonism,
deafness, and neuropathy. Ann Neurol 2000;48:730-6.
53. Horvath R, Kley RA, Lochmuller H, Vorgerd M. Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G
(MERRF) in tRNALys. Neurology 2007;68:568.
54. Martikainen MH, Kytovuori L, Majamaa K. Juvenile parkinsonism, hypogonadism and Leigh-like MRI changes in a patient with
m.4296G > A mutation in mitochondrial DNA. Mitochondrion 2013;13:83-6.
55. De Coo IF, Renier WO, Ruitenbeek W, Ter Laak HJ, Bakker M, et al. A 4-base pair deletion in the mitochondrial cytochrome b gene
associated with parA 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap
syndrome. Ann Neurol 1999;45:130-3.
56. Rana M, de Coo I, Diaz F, Smeets H, Moraes CT. An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is
associated with impaired complex III assembly and an increase in free radical production. Ann Neurol 2000;48:774-81.
57. Simon DK, Pulst SM, Sutton JP, Browne SE, Beal MF, et al. Familial multisystem degeneration with parkinsonism associated with the